SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-048168
Filing Date
2020-10-28
Accepted
2020-10-28 08:04:14
Documents
51
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q odt-10q_20200930.htm   iXBRL 10-Q 1266757
2 EX-31.1 odt-ex311_6.htm EX-31.1 18263
3 EX-31.2 odt-ex312_7.htm EX-31.2 18345
4 EX-32.1 odt-ex321_8.htm EX-32.1 15080
5 GRAPHIC gp1gfe0uwexh000001.jpg GRAPHIC 29283
  Complete submission text file 0001564590-20-048168.txt   4016292

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA odt-20200930.xsd EX-101.SCH 29548
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE odt-20200930_cal.xml EX-101.CAL 29750
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE odt-20200930_def.xml EX-101.DEF 56345
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20200930_lab.xml EX-101.LAB 238769
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20200930_pre.xml EX-101.PRE 167480
11 EXTRACTED XBRL INSTANCE DOCUMENT odt-10q_20200930_htm.xml XML 557471
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38318 | Film No.: 201266250
SIC: 2834 Pharmaceutical Preparations